PF-04856880

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NamePF-04856880
Drug Alias NameADL-5859PF-04856880PF-4856880
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionδ-opioid receptor agonists
Targetsδ-opioid receptor
Therapy Area/IndicationsAcute PainNeuralgiaPeripheral Nervous System Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCubist Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsAcute PainNeuralgiaPeripheral Nervous System Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A